Regulation of DNA Damage Responses
- 格式:pdf
- 大小:1016.86 KB
- 文档页数:13
2013年全球华人生物科学家大会The 14th SCBA International Symposium第三轮通知2013年7月18-22日中国·西安欢迎词我们非常诚挚地邀请您参与将于2013年7月18日至22日在中国西安召开“2013年全球华人生物科学家大会(The 14th SCBA International Symposium)”。
生命科学作为当今发展最快、最活跃、与人类生活最密切相关的科学,在过去几十年中,尤其是二十一世纪前十几年间,生命科学领域的研究加深了人类对于生命本质的认知。
分子生物学、基因组科学、干细胞生物学以及多种生命科学相关交叉学科的建立和发展,为农业、医学、能源、环境等诸多领域的开发提供了强有力的手段。
为促进生命科学的发展、增进本领域科学家之间的交流合作、提升华人世界生命科学的研究水平,美洲华人生物科学学会(SCBA)、中国工程院将主办,并由第四军医大学、中国转化医学与生物技术创新联盟承办2013年全球华人生物科学家大会。
大会特别邀请诺贝尔奖获得者、美国科学院院士、中国两院院士及其他国际著名的专家、学者、教授报告当今生命科学领域及其交叉学科中的最新成果与发展趋势。
会议期间还将组织青年优秀论文、优秀墙报评奖活动,力争为参会者搭建一个良好的交流平台。
本次大会受到了中国中央政府和陕西省政府等各部门的高度重视和关怀。
西安作为具有悠久文化历史的十三朝古都,拥有秦始皇陵兵马俑等世界文化遗产和浓厚的汉风古韵。
我们还为每位参会代表安排了独具特色的文化旅游。
相信您在学术交流之余,还能领略到八百里秦川的风土人情和几千年历史的深厚底蕴。
再次感谢您的积极关注和大力支持!让我们2013年7月相聚在西安!大会主席:王小凡共同主席:陈志南2013年全球华人生物科学家大会组委会2013年3月一、大会主题:探索未来,维护健康二、大会主办、承办、协办单位:主办单位:华人生物学家协会,中国工程院医药卫生学部承办单位:第四军医大学,中国转化医学与生物技术创新联盟协办单位:浙江大学,中国生物化学与分子生物学学会,中国免疫学会,中国细胞生物学学会细胞工程与转基因生物分会三、大会组织机构:名誉主席:陈竺大会主席:王小凡共同/执行主席:陈志南主席团顾问组:曹雪涛陈赛娟陈香美陈晓亚程京丛斌邓子新丁健董欣年段树民樊代明傅向东葛均波郭爱克贺福初何维黄路生景乃禾康乐李大鹏李家洋李林林其谁孟安明裴钢邱贵兴饶子和尚永丰施一公施蕴瑜舒红兵王恩多王红阳王晓东王志新魏于全徐建国杨宝峰于金明许智宏袁钧瑛曾益新詹启敏张明杰张启发张学敏张亚平赵国屏赵进东赵玉沛朱健康朱玉贤朱英国 Kenneth Fong Horace LohMien-Chie Hung Joseph Li Choong-Chin Liew Jean ShihLap-Chee Tsui Savio Woo Robert Yu学术委员会主席:王小凡陈志南 Jim Hu学术委员会委员:陈晔光, Genhong Cheng, Gensheng Feng, 冯新华, Zhong-Ping FengKwok Pui Fung, 韩家淮, Choy Leong Hew, Hong Nerng HoTao-Shih Hsieh, Wei Li, Yi Li, 李松,栗占国,罗晓星,彭金荣, Yang ShiYun-Bo Shi, Bing Su, Zhou Songyang, Ming-Jer Tsai, Jian-Ying WangTC Wu, 曾小峰,张奉春,Keji Zhao, Richard Zhao,朱平,邹全明组织委员会主席:陈志南冯新华组织委员会委员:边惠洁,Chien-Jen Chen, 崔洪勇,党小荣,Jim Hu, Mien-Chie Hung 蒋建利,Hsing-Jien Kung, 李玲,李郁,Peter Liu, Horace LohMing-Jer Tsai, 王晓东, TC Wu, 徐静,杨向民,Dihua Yu, Richard ZhaoHui Zheng评奖委员会主席:Dihua Yu评奖委员会委员:冯新华, WanJin Hong, Hsing-Jien Kung, 黎孟枫, Yun-Bo Shi, 王小凡TC Wu, Dihua Yu会务组主任:蒋建利会务组成员:郭婷,苏丽,杨荣荣,郝赋因四、会议时间:2013年7月18日报到,19-22日会议交流。
Cellular Stress ResponsesCellular stress responses are critical mechanisms that allow cells to adapt to and cope with various environmental stressors. These stressors can be physical, chemical, or biological in nature and can cause damage to cellular components such as DNA, proteins, and membranes. In response to stress, cells activate a complex network of signaling pathways that coordinate a range of cellular processes aimed at restoring cellular homeostasis. In this essay, I will explore the various cellular stress responses, their underlying mechanisms, and their significance in maintaining cellular function.One of the most well-known cellular stress responses is the heat shock response. This response is activated in cells exposed to high temperatures, and it involves the upregulation of a group of proteins known as heat shock proteins (HSPs). HSPs play a crucial role in protecting cells from heat-induced damage by stabilizing proteins and preventing their denaturation. The heat shock response is also activated in response to other stressors such as oxidative stress and exposure to toxins, highlighting the versatility of this response.Another important cellular stress response is the unfolded protein response (UPR). This response is activated when cells are unable to properly fold newly synthesized proteins, leading to the accumulation of misfolded proteins in the endoplasmic reticulum (ER). The UPR involves a complex signaling pathway that aims to restore ER homeostasis by reducing protein synthesis, increasing protein folding capacity, and degrading misfolded proteins. Failure to activate the UPR can lead to the accumulation of misfolded proteins, which can cause cell death or contribute to the development of various diseases such as Alzheimer's and Parkinson's.The DNA damage response (DDR) is another critical cellular stress response that is activated in response to DNA damage caused by various stressors such as radiation, chemicals, and oxidative stress. The DDR involves a complex signaling pathway that coordinates DNA repair, cell cycle arrest, and apoptosis. Failure to properly activate the DDR can lead to the accumulation of DNA damage, which can contribute to the development of various diseases such as cancer.The autophagy pathway is another important cellular stress response that is activated in response to a range of stressors such as nutrient deprivation, oxidative stress, and infection. Autophagy is a process by which cells degrade and recycle damaged or unnecessary cellular components such as organelles and proteins. This process is critical for maintaining cellular homeostasis and preventing the accumulation of damaged components that can contribute to the development of various diseases.The cellular stress response is also closely linked to the immune system, with stress responses playing a critical role in the innate and adaptive immune responses. For example, the activation of the UPR has been shown to stimulate the production of cytokines and chemokines, which play a crucial role in the immune response. Similarly, the autophagy pathway is critical for the degradation of intracellular pathogens and the presentation of antigens to the immune system.In conclusion, the cellular stress response is a critical mechanism that allows cells to adapt to and cope with various environmental stressors. These stress responses involve complex signaling pathways that coordinate a range of cellular processes aimed at restoring cellular homeostasis. The significance of these stress responses is highlighted by their role in preventing the development of various diseases such as cancer, Alzheimer's, and Parkinson's. The cellular stress response is a fascinating area of research that holds great promise for the development of new therapies aimed at treating a range of diseases.。
p53基因参与dna损伤修复途径英文回答:The p53 gene plays a critical role in the DNA damage response pathway, which is responsible for detecting and repairing DNA damage. When DNA is damaged, the p53 protein is activated and induces a variety of cellular responses, including cell cycle arrest, DNA repair, and apoptosis.p53 is a tumor suppressor gene, and mutations in p53 are commonly found in cancer cells. These mutations can lead to the loss of p53 function, which results in increased genomic instability and an increased risk of cancer development.The p53 protein is a transcription factor, and it regulates the expression of a number of genes involved in the DNA damage response pathway. These genes include those involved in DNA repair, cell cycle regulation, and apoptosis.The p53 protein is also involved in the regulation of cellular metabolism. For example, p53 can induce the expression of genes involved in glycolysis and oxidative phosphorylation. This helps to provide the energy needed for DNA repair and other cellular processes.The p53 protein is a key regulator of the DNA damage response pathway, and it plays a critical role in maintaining genomic stability and preventing cancer development.中文回答:p53基因参与DNA损伤修复途径,该途径负责检测和修复DNA 损伤。
碧云天生物技术/Beyotime Biotechnology 订货热线:400-168-3301或800-8283301 订货e-mail :****************** 技术咨询:***************** 网址:碧云天网站 微信公众号BCA 蛋白浓度测定试剂盒(增强型)产品编号 产品名称包装 P0010SBCA 蛋白浓度测定试剂盒(增强型)200次产品简介:BCA 蛋白浓度测定试剂盒(增强型) (Enhanced BCA Protein Assay Kit)是根据目前世界上最常用的两种蛋白浓度检测方法之一BCA 法研制而成,实现了蛋白浓度测定的简单、高稳定性、高灵敏度和高兼容性。
和碧云天生产的普通BCA 蛋白浓度测定试剂盒相比,灵敏度更高,检测浓度下限达到10µg/ml ,最小检测蛋白量达到0.2µg ,待测样品体积为1-20µl 。
和碧云天生产的普通BCA 蛋白浓度测定试剂盒相比,显色速度更快,相同的样品孵育较短时间即可进行吸光度测定。
在20-1000µg/ml 浓度范围内有较好的线性关系。
本产品从0.025到0.5mg/ml 的标准曲线参考图1。
图1. 本试剂盒蛋白标准曲线的效果图。
左图为加入BCA 工作液后37ºC 分别孵育30、60和120分钟后的吸光度实测效果图,右图为37ºC 孵育60分钟时的实际显色效果图。
图中数据仅供参考,实际的检测效果可能会略有不同。
BCA 法测定蛋白浓度不受绝大部分样品中的化学物质的影响,可以兼容样品中高达5%的SDS ,5%的Triton X-100,5%的Tween20、60、80。
但本试剂盒受螯合剂和略高浓度的还原剂的影响,需确保EDTA 低于10mM ,无EGTA ,二硫苏糖醇(DTT)低于1mM ,β-巯基乙醇(β-Mercaptoethanol)低于0.01%。
不适用BCA 法时建议试用碧云天生产的Bradford 蛋白浓度测定试剂盒(P0006)。
- 172 -*基金项目:国家自然科学基金青年项目(81903119);中山大学高校基本科研业务费青年教师培育项目(20ykpy52)①中山大学附属第一医院 广东 广州 510080通信作者:毕月乳腺癌放疗抵抗机制的研究进展*毕月① 【摘要】 放疗是鼻咽癌、乳腺癌及直肠癌等多种恶性肿瘤的重要治疗手段,不过部分患者会出现放疗抵抗的现象,造成转移及复发,从而降低患者生存率。
乳腺癌患者放疗抵抗的发生与多种因素有关,如肿瘤干细胞及肿瘤微环境等。
乳腺癌放疗患者的治疗效果与放疗抵抗密切相关,对放疗抵抗的产生机制进行研究有助于减少或者抑制放疗抵抗,提高放疗效果,改善患者预后。
本文从肿瘤干细胞、自噬性调节及DNA 损伤修复等多个方面做一综述,旨在为随后研究提供思路。
【关键词】 乳腺癌 放疗抵抗 肿瘤干细胞 自噬性调节 细胞周期调控 上皮间充质转化 DNA 损伤修复 Research Progress on the Mechanism of Radiotherapy Resistance in Breast Cancer/BI Yue. //Medical Innovation of China, 2023, 20(30): 172-176 [Abstract] Radiotherapy is an important treatment method for nasopharyngeal carcinoma, breast cancer, rectal cancer and other malignant tumors. However, some patients may experience resistance to radiotherapy, which may cause metastasis and recurrence, thus reducing the survival rate of patients. The occurrence of radiotherapy resistance in breast cancer patients is related to many factors, such as cancer stem cell and tumor microenvironment. The therapeutic effect of breast cancer patients undergoing radiotherapy is closely related to their resistance to radiotherapy. Studying the mechanism of resistance to radiotherapy can help reduce or inhibit resistance to radiotherapy, improve the effect of radiotherapy, and improve the prognosis of patients. This article reviews cancer stem cell, autophagy regulation, DNA damage repair and other aspects in order to provide ideas for subsequent research. [Key words] Breast cancer Radiotherapy resistance Cancer stem cell Autophagy regulation Cell cycle regulation Epithelial mesenchymal transformation DNA damage repair First-author's address: First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China doi:10.3969/j.issn.1674-4985.2023.30.040 乳腺癌是严重危害女性身心健康的一种恶性肿瘤。
乳酸化修饰组学英文Lactate-modified ProteomicsProteomics, the large-scale study of proteins, has emerged as a powerful tool in the field of biological research. One of the key aspects of proteomics is the investigation of post-translational modifications (PTMs), which are chemical changes that occur to proteins after their synthesis. Among the various PTMs, lactate-modification, also known as lactoylation, has gained significant attention in recent years.Lactoylation is a reversible PTM in which a lactate moiety is covalently attached to specific amino acid residues within a protein. This modification can have profound effects on the structure, function, and localization of the modified proteins, making it a crucial regulator of cellular processes. The study of lactoylation, or lactate-modified proteomics, has become an increasingly important field in the quest to understand the complex mechanisms underlying biological systems.One of the primary reasons for the growing interest in lactate-modified proteomics is the central role of lactate in cellularmetabolism. Lactate, a byproduct of anaerobic glycolysis, is typically associated with hypoxic or rapidly proliferating cells, such as those found in cancer or inflammatory environments. However, recent studies have revealed that lactate can also act as a signaling molecule, influencing various cellular processes, including gene expression, protein function, and cellular metabolism.The lactoylation of proteins can have diverse effects on their activities. For instance, lactoylation of certain transcription factors can alter their DNA-binding abilities, leading to changes in gene expression patterns. Similarly, lactoylation of metabolic enzymes can modulate their catalytic activities, thereby influencing the overall metabolic state of the cell. Additionally, lactoylation can affect protein-protein interactions, subcellular localization, and even protein stability, highlighting the multifaceted nature of this PTM.To study lactate-modified proteomics, researchers employ a variety of analytical techniques, including mass spectrometry, affinity-based enrichment, and advanced bioinformatics tools. Mass spectrometry, in particular, has been a crucial tool in the identification and quantification of lactoylated proteins. By coupling mass spectrometry with sophisticated data analysis algorithms, researchers can detect and characterize the specific sites of lactoylation within a protein, as well as the relative abundance of the modified forms compared to the unmodified counterparts.The application of lactate-modified proteomics has led to significant advancements in our understanding of cellular physiology and pathology. For instance, studies have revealed the role of lactoylation in the regulation of cellular stress responses, immune function, and cancer metabolism. In the context of cancer, lactoylation of proteins involved in glycolysis, angiogenesis, and cell survival pathways has been observed, suggesting that targeting the lactate-modification machinery could be a promising therapeutic approach.Furthermore, lactate-modified proteomics has also been employed in the investigation of other disease states, such as neurodegenerative disorders, cardiovascular diseases, and metabolic syndromes. By elucidating the specific proteins and pathways affected by lactoylation in these conditions, researchers can gain valuable insights into the underlying mechanisms and potentially identify novel diagnostic biomarkers or therapeutic targets.Beyond its applications in disease research, lactate-modified proteomics also holds promise in the field of biotechnology and industrial microbiology. Understanding the role of lactoylation in the regulation of microbial enzymes, metabolic pathways, and cellular processes can aid in the optimization of fermentation processes, the development of more efficient biocatalysts, and the engineering of microorganisms for the production of valuable compounds.In conclusion, the field of lactate-modified proteomics has emerged as a crucial branch of proteomics research, offering unprecedented insights into the complex interplay between cellular metabolism and protein function. As our understanding of the biological significance of lactoylation continues to evolve, the potential applications of this field in biomedicine, biotechnology, and beyond are expected to expand, paving the way for groundbreaking discoveries and advancements in various scientific domains.。
植物学英文缩写Plant Biology Abbreviations。
Plant biology is a vast field of study that encompasses various aspects of plant life, including their structure, growth, development, and interactions with the environment. To facilitate communication and make scientific writing more concise, researchers and scientists often use abbreviations for plant-related terms. In this article, we will explore some commonly used abbreviations in the field of plant biology.1. DNA: Deoxyribonucleic Acid。
DNA is the genetic material found in all living organisms, including plants. It carries the instructions for the development, functioning, and reproduction of plants. DNA is composed of two strands twisted together in a double helix structure and contains the genetic code that determines the traits and characteristics of plants.2. RNA: Ribonucleic Acid。
CHD4蛋白截短体融合蛋白的表达、纯化和鉴定徐涛;张金莉;曾妍;王攀;郎慧芳;万传君;顾永清【摘要】目的构建CHD4/Mi-2β基因的截短体原核表达重组质粒,在大肠杆菌中诱导表达并对GST融合蛋白进行纯化和初步鉴定.方法采用PCR方法扩增CHD4/Mi-2β的染色质调节区(CHD4-C)、解螺旋酶模序(CHD4-H)及DNA结合区(CHD4-D)基因片段,将目的基因片段插入原核表达载体pGEX-5T构建带GST标签的重组质粒,阳性克隆行DNA序列测定.IPTG诱导GST-CHD4-C、GST-CHD4-D和GST-CHD4-H原核表达,谷胱甘肽琼脂糖珠纯化融合蛋白,并对融合蛋白Western blot鉴定.结果构建了3个CHD4/Mi-2β基因的截短体重组质粒;IPTG 诱导显示,GST-CHD4-C、GST-CHD4-D和GST-CHD4-H融合蛋白主要以可溶性蛋白形式在细胞裂解液上清中表达,表达产物的相对分子质量分别为130、110、90ku.谷胱甘肽琼脂糖珠纯化融合蛋白,纯化产物的纯度最高可达94.5%.Western blot证实各融合蛋白与抗GST单克隆抗体发生特异性结合反应,分子质量与估计值相符,提示为GST融合表达的CHD4/Mi-2β截短体蛋白.结论成功纯化了较高纯度的GST-CHD4-C、GST-CHD4-D和GST-CHD4-H融合蛋白,为进一步研究CHD4蛋白在染色质重塑中的作用奠定了实验基础.【期刊名称】《西安交通大学学报(医学版)》【年(卷),期】2014(035)001【总页数】4页(P12-15)【关键词】CHD4/Mi-2β;pGEX-5T;融合蛋白;蛋白表达;纯化【作者】徐涛;张金莉;曾妍;王攀;郎慧芳;万传君;顾永清【作者单位】军事医学科学院放射与辐射医学研究所放射毒理与辐射危害评价研究室,北京,100850;石河子大学医学院生化教研室,新疆石河子,832000;石河子大学医学院生化教研室,新疆石河子,832000;石河子大学医学院生化教研室,新疆石河子,832000;军事医学科学院放射与辐射医学研究所放射毒理与辐射危害评价研究室,北京,100850;石河子大学医学院生化教研室,新疆石河子,832000;南通大学附属医学院消化科实验室,江苏南通,226000;驻马店卫生学校微生物免疫教研室,河南驻马店,463000;军事医学科学院放射与辐射医学研究所放射毒理与辐射危害评价研究室,北京,100850;石河子大学医学院生化教研室,新疆石河子,832000【正文语种】中文【中图分类】Q816人类CHD4/Mi-2β蛋白属于ATP酶超家族,该蛋白质因氨基端开始依次含有染色质调节域(ATP-dependent chromatin-remodeling complexes)、类SWI2/SNF2 ATP酶/解螺旋酶域和DNA结合域而得名[1]。
Regulation of DNA Damage Responsesby Ubiquitin and SUMOStephen P.Jackson1,*and Daniel Durocher2,3,*1The Gurdon Institute and the Department of Biochemistry,University of Cambridge,Cambridge CB21QN,UK2Samuel Lunenfeld Research Institute,Mount Sinai Hospital,600University Avenue,Toronto,ON M5G1X5,Canada3Department of Molecular Genetics,University of Toronto,Toronto,ON M5S1A8,Canada*Correspondence:s.jackson@(S.P.J.),durocher@lunenfeld.ca(D.D.)/10.1016/j.molcel.2013.01.017Ubiquitylation and sumoylation,the covalent attachment of the polypeptides ubiquitin and SUMO,respec-tively,to target proteins,are pervasive mechanisms for controlling cellular functions.Here,we summarize the key steps and enzymes involved in ubiquitin and SUMO conjugation and provide an overview of how they are crucial for maintaining genome stability.Specifically,we review research that has revealed how ubiq-uitylation and sumoylation regulate and coordinate various pathways of DNA damage recognition,signaling, and repair at the biochemical,cellular,and whole-organism levels.In addition to providing key insights into the control and importance of DNA repair and associated processes,such work has established paradigms for regulatory control that are likely to extend to other cellular processes and that may provide opportunities for better understanding and treatment of human disease.Principles of Ubiquitylation and SumoylationAlthough initially discovered as a mechanism targeting proteins for destruction by the proteasome,ubiquitylation—the covalent attachment of the76amino acid residue protein ubiquitin to other proteins—is now also known to regulate protein activity, localization,and interactions(Bergink and Jentsch,2009; Komander and Rape,2012).In addition to ubiquitin,there are several ubiquitin-like proteins(UBLs)that are structurally related to ubiquitin.Ubiquitin and most UBLs are attached via their C-terminal glycine residues to target proteins by enzymatic reactions mediated by E1,E2,and E3ligases(Figure1).The most widely characterized UBL is the 100residue protein SUMO(small ubiquitin-related modifier).Eukaryotes usually contain a single type of ubiquitin that is encoded by multiple genes.By contrast,vertebrate cells possess two types of SUMO:SUMO-1and the highly related proteins SUMO-2and SUMO-3(SUMO2/3)that appear to be functionally redundant. Simpler organisms such as Saccharomyces cerevisiae and Schizosaccharomyces pombe,however,contain a single SUMO (Smt3and Pmt3,respectively).In mammals,ubiquitylation involves two E1s,over35E2s,and over600E3s,while sumoy-lation is mediated by a single heterodimeric E1,one E2(UBC9/ UBE2I),and approximately ten E3s.Ubiquitin and SUMO are usually attached to substrates via isopeptide linkages between their C termini and theεNH2group of Lys residues on target proteins.In some cases,the target protein has a single ubiquitin or SUMO attached,while in others, several can be individually attached to multiple Lys residues on the target.Furthermore,because ubiquitin and some SUMOs possess modifiable lysine residues,conjugation cycles can often be repeated to produce polymeric chains(Bergink and Jentsch, 2009).In the case of ubiquitin,seven Lys residues can be used (Lys6,Lys11,Lys27,Lys29,Lys33,Lys48,and Lys63)along with the amino group of the N-terminal Met.SUMO2/3but not SUMO1bear internal sumoylatable Lys residues that can be used to form chains,while SUMO1can be conjugated as a chain-terminator.Consistent with different ubiquitin and SUMO chains having different structures and physical properties,they have distinct functions.For example,while Lys48-,Lys29-,and Lys11-linked ubiquitin chains promote target-protein degrada-tion by the proteasome,Lys63chains generally regulate protein-protein interactions.There is also evidence for ubiquitin chains with mixtures of linkages(Komander and Rape,2012), as well as chains containing both ubiquitin and SUMO(Praefcke et al.,2012).Like other posttranslational modifications,sumoylation and ubiquitylation are reversible.While SUMO-protein isopeptide bonds are cleaved by a small family of peptidases(SENP1–SENP3and SENP5–SENP7),there are 100deubiquitylating enzymes(also known as deubiquitylases or DUBs).DUBs are grouped intofive families:ubiquitin C-terminal hydrolases (UCHs),ubiquitin-specific proteases(USPs)and ovarian tumor proteases(OTUs),the Josephins,and the Jab1/MPN/Mov34 family(JAMM/MPN+).Thefirst four families are Cys proteases, whereas the latter comprises Zn2+-dependent metalloproteases (Nijman et al.,2005).In addition to opposing ubiquitin/SUMO ligase activities,certain DUBs and SENPs process ubiquitin and SUMO precursors,and some DUBs are intrinsic compo-nents of the proteasome.DNA Repair and the DNA Damage ResponseGenome integrity is continuously undermined by exogenous and endogenously generated DNA-damaging chemicals,ionizing radiation(IR)and ultraviolet(UV)radiation,and by errors in DNA replication.To mitigate this,cells possess highly effective mechanisms—collectively called the DNA damage response (DDR)—to detect,signal,and repair DNA lesions.These pro-cesses have profound impacts on normal cell and organism physiology,with their deregulation or loss causing genome instability syndromes that are associated with cancer,stem Molecular Cell49,March7,2013ª2013Elsevier Inc.795cell exhaustion,developmental defects,infertility,immune defi-ciency,neurodegenerative disease,and premature aging (Jack-son and Bartek,2009).Different DNA lesions are repaired by distinct systems.Thus,DNA double-strand breaks (DSBs)are repaired by nonhomolo-gous end joining (NHEJ),alternative NHEJ,or homologous recombination (HR),UV-induced DNA lesions,and other bulky DNA adducts are repaired by nucleotide excision repair (NER),simpler base lesions are repaired by base-excision repair (BER)whose components and reactions overlap with those of single-strand break repair,and DNA base mismatches are corrected by mismatch repair (MMR),while the Fanconi anemia (FA)pathway repairs DNA crosslinks.Lesions are first recog-nized by proteins that trigger and coordinate the recruitment and activities of additional DNA repair components.DNA damage induction elicits cascades of posttranslational modi-fications,including phosphorylation,ubiquitylation,and sumoy-lation that orchestrate the aforementioned processes as well as additional aspects of the DDR,such as regulating deoxyribo-nucleotide supply and triggering of cell-cycle delays (cell-cycle checkpoints).These events are largely initiated by the apical DDR kinases ATM and ATR,whose importance in coordinating the DDR is illustrated by their mutation in Ataxia-telangiectasia (A-T)and Seckel syndrome,respectively (Durocher and Jack-son,2001;Kerzendorfer and O’Driscoll,2009).In this review,we focus on the rapidly emerging functions of ubiquitin and SUMO in controlling various aspects of the DDR,with a particular emphasis on responses to DSBs,which are the most cytotoxic of all DNA lesions.Ubiquitylation and Postreplication RepairThe first association between DNA repair and ubiquitylation arose when yeast Rad6,which functions in postreplication repair (PRR),was shown to be a ubiquitin E2(Jentsch et al.,1987).PRR is a DNA-damage-tolerance pathway that allows replication past bulky DNA lesions and is orchestrated by ubiquitylation and sumoylation of the DNA polymerase processivity factor PCNA (Figure 2).Two subpathways comprise eukaryotic PRR:trans-lesion synthesis (TLS),and a template-switch mechanism asso-ciated with HR (Ulrich,2011).An early step in yeast PRR is PCNA monoubiquitylation by the RING-type E3,Rad18,in conjunction with the E2,Rad6(Hoege et al.,2002;Stelter and Ulrich,2003).PCNA is primarily monoubiquitylated on Lys164,with this modi-fication being recognized by specialized TLS polymerases such as Pol h ,Pol i ,Pol k ,and Pol z via their ubiquitin-binding domains (UBDs)of the UBM and UBZ families in conjunction with motifs such as PIP boxes that recognize other features of PCNA (Lehmann,2011).Unlike canonical high-fidelity polymerases,the catalytic sites of TLS polymerases can synthesize over and past DNA lesions but usually at the cost of fidelity,thus making them error prone.Yeast PCNA can also be polyubiquitylated on Lys164by Rad5(Hoege et al.,2002),an E3ligase that coop-erates with a dimeric E2Ubc13-Mms2.Rad5-Ubc13-Mms2yields Lys63-linked ubiquitin chains on PCNA that promote the template-switching pathway that involves the newlysynthesizedFigure 1.The Ubiquitin and UBL Conjugation CycleUbiquitin and SUMO are produced as precursor polypeptides that are first processed to reveal a C-terminal diglycine motif (1).An E1enzyme then uses ATP to convert this motif into a high-energy-bond containing adenylated derivative,which is short-lived,rapidly reacting with a Cys in the E1to form a E1 Ub or E1 SUMO thioester intermediate (2).The ubiquitin or SUMO moieties are then coupled,via a transesterification reaction,onto a Cys residue in the E2catalytic site to form E2 Ub/SUMO intermediates (3).In most cases,an E3ligase serves as a substrate adaptor,linking the charged E2and the substrate (4).Ubiquitylation or sumoylation can be reversed by a DUB (for ubiquitin)or a SENP (for SUMO)(5)or the modification cycle can be repeated to produce chains of various topologies (6).The (*)indicates that other types of enzymes can remove UBLmodifications.Figure 2.The roles of Ubiquitin and SUMO in Postreplication Repair(A)PCNA monoubiquitylation on Lys164occurs when replication forks encounter lesions (star).The single-stranded DNA is recognized by the Rad18E3ligase,which interacts with Rad6,an E2,to ubiquitylate PCNA.PCNA ubiquitylation recruits Y family polymerases such as Pol h to bypass the lesion in the process termed translesion synthesis (TLS).In vertebrates the USP1-UAF1DUB opposes PCNA monoubiquitylation.(B)A second DNA damage tolerance pathway termed template switching occurs when PCNA is polyubiquitylated by the E3Rad5and the Ubc13/Mms2dimeric E2.Template switching employs homologous recombination.(C)In yeast,PCNA sumoylation on its Lys164residue recruits Srs2,which acts as an antirecombinase by disrupting Rad51nucleoprotein filaments.796Molecular Cell 49,March 7,2013ª2013Elsevier Inc.sister chromatid and the HR machinery.While it is still unclear how PCNA ubiquitylation promotes template switching,the mammalian ZRANB3translocase was recently identified as an effector of PCNA polyubiquitylation(Zeman and Cimprich, 2012).While differences in PRR may exist between yeast and man, the pathway has been generally evolutionarily conserved,with mammals having counterparts of Rad6(human HR6A/UBE2A and HR6B/UBE2B),Rad18(RAD18),and Rad5(SHPRH and HLTF).Knockout or depletion of RAD18in a variety of species results in defective PRR,PCNA monoubiquitylation,and accu-mulation of TLS polymerases such as Pol h at sites of replication fork blockage(Lee and Myung,2008).Furthermore,small inter-fering RNA depletion studies suggest that human HLTF and SHPRH contribute to PCNA polyubiquitylation in response to fork-causing lesions(Motegi et al.,2008)and in the suppression of mutagenesis(Lin et al.,2011),phenotypes consistent with functions for these E3ligases in error-free PRR.In addition to being ubiquitylated,budding yeast PCNA is sumoylated on Lys164(and to a lesser degree on Lys127)by the E3Siz1and the E2Ubc9(Pfander et al.,2005;Stelter and Ulrich,2003).PCNA sumoylation prevents unscheduled recom-bination during DNA replication by recruiting Srs2,a UvrD-type helicase that can strip the key HR protein Rad51from chromatin (Krejci et al.,2003;Pfander et al.,2005;Veaute et al.,2003).Srs2 harbors PCNA-binding PIP and SUMO-interaction motif(SIM) regions that simultaneously engage sumoylated PCNA(Arm-strong et al.,2012).While PCNA sumoylation is difficult to detect in human cells,an Srs2-like protein,PARI,has recently been described(Moldovan et al.,2012).Control of NER by UbiquitylationNER repairs bulky DNA base adducts and ultraviolet light-induced lesions.Inherited defects in NER factors yield patho-logies that include xeroderma pigmentosum(XP),Cockayne syndrome(CS),and trichothiodystrophy(TTD),which are char-acterized by sun hypersensitivity,skin cancer predisposition (in the case of XP),cognitive impairments,premature aging,or developmental defects(Hoeijmakers,2009).NER comprises two main pathways:global genome repair(GG-NER)that oper-ates on all nuclear DNA,and transcription-coupled repair(TC-NER)that specifically targets the template strand of transcribed genes.During human GG-NER,DNA lesions can be detected independently by two complexes,DDB1-DDB2/XPE and XPC-RAD23(Scrima et al.,2011)(Figure3).However,DDB1-DDB2 plays a unique role in NER owing to the observation that DDB1-DDB2is required for the effective recruitment of XPC to chromatin(Fitch et al.,2003).Mechanistically,DDB2-DDB1 forms an E3ligase in association with CUL4A/B that mediates monoubiquitylation of histones and polyubiquitylation of DDB2 and XPC(Scrima et al.,2011).While autoubiquitylated DDB2is targeted for degradation,XPC is not because it is protected from proteasome action by RAD23,a proteasome-interacting protein(El-Mahdy et al.,2006;Sugasawa,2006;and references therein).When RNA polymerase II(RNAP II)stalls upon encountering a DNA lesion,two independent cascades can be triggered. Thefirst event is TC-NER,and the second is the ubiquitylation,extraction,and degradation of RNAP II from chromatin(Figure3). TC-NER is dependent on CSB(ERCC6),a SWI/SNF family protein that associates with RNAP II(Gaillard and Aguilera, 2013).In addition to possessing chromatin-remodeling activity, CSB recruits CSA(ERCC8)to sites of DNA damage,the latter forming an E3with DDB1and CUL4.The action of CSB and CSA may be to license the TC-NER process,which includes RNAP II backtracking and subsequent recruitment of the core NER machinery(Gaillard and Aguilera,2013).The identity of the key ubiquitylation event that initiates TC-NER is still unknown,but RNAP II and CSB ubiquitylation are possibilities. In that regard,CSB possess a functionally important UBD,sug-gesting that CSB recognizes this key ubiquitylation event(Anin-dya et al.,2010).Furthermore,the DUB USP7is recruited to stalled polymerases by UVSSA,the product of a gene mutated in a CS-like UV-sensitivity syndrome(Cleaver,2012).UVSSA-USP7interacts with RNAP II and delays the CSA-dependent degradation of CSB by the proteasome.The degradation of RNAP II by the proteasome can be seen as a last-resort measure and provides a unique case study for the role of ubiquitin chain editing.In yeast,these processes involve the Rsp5E3(NEDD4in mammals),which catalyzes Lys63-linked ubiquitin chain formation on RNAP II(Anindya et al.,2007;Wilson et al.,2013).These chains are trimmed down by Ubp2,a DUB, resulting in monoubiquitylated RNAP II.Lys48-linked ubiquitin chains are then built from monoubiquitylated RNAP II by an Elongin/Cullin3complex,which can then promote RNAP II degradation after its extraction from chromatin with the Cdc48 segregase,the yeast VCP/p97homolog(Harreman et al., 2009;Verma et al.,2011;Wilson et al.,2013).Ubiquitin-Based DSB Signaling by RNF8and RNF168An important paradigm for ubiquitin and SUMO acting in intra-cellular signaling is provided by the orchestrated recruitment of proteins such53BP1and the tumor suppressor BRCA1onto chromatin surrounding DSB sites(Lukas et al.,2011)(Figure4). These events are initiated by phosphorylation of the histone variant H2AX(yielding g H2AX),which is recognized by MDC1 (Stucki et al.,2005).MDC1is then phosphorylated by the DSB-responsive kinase ATM,with these phospho-sites being bound by the FHA domain of the RING-E3ligase RNF8(Huen et al., 2007;Kolas et al.,2007;Mailand et al.,2007).RNF8then medi-ates ubiquitylation of proteins at DSB sites in a manner promoted via interactions with the large HECT-type ligase HERC2(Bekker-Jensen et al.,2010).The RING-E3ligase RNF168is then re-cruited by its UBDs,recognizing RNF8ubiquitylation products and products of its own activity.The UBDs of RNF168are not equivalent and are integrated in functional modules containing targeting motifs,the LRMs that are also present on RAD18and RAP80(Panier et al.,2012).The primary outcome of RNF8/ RNF168-dependent ubiquitylation is recruitment and/or reten-tion of DSB repair and signaling factors on chromatin surround-ing the DNA lesion,which include53BP1,RAD18,BRCA1,the RAP80complex(also known as BRCA1-A),HERC2,BMI1, RIF1,RNF169,NPM1,FAAP20,and NIPBL(Lukas et al.,2011). At the functional level,RNF8/RNF168-dependent ubiquitylation promotes NHEJ during immunoglobulin class switching and dysfunctional telomere fusion(Kracker and Durandy,2011;Molecular Cell49,March7,2013ª2013Elsevier Inc.797Peuscher and Jacobs,2011;Rai et al.,2011).In addition to NHEJ,the RNF8pathway can also promote HR.These repair defects likely contribute to the clinical phenotypes observed in individuals with inactivating mutations in RNF168,which are afflicted with an immunodeficiency and cellular radiosensitivity syndrome,RIDDLE,that is related to A-T (Stewart et al.,2009).Significantly,the RNF8pathway is turned off during mitosis,perhaps because chromatin ubiquitylation is incompatible with mitotic progression (Giunta et al.,2010).In another striking example of regulation,it recently emerged that RNF168is a limiting factor in the RNF8pathway,with the E3ubiquitin ligases TRIP12and UBR5collaborating to regulate RNF168levels,thereby preventing excessive histone ubiquitylation at DSB sites (Gudjonsson et al.,2012).It will be interesting todeter-Figure 3.The Role of Ubiquitin in Nucleotide Excision Repair(A)GG-NER promotes the repair of bulky lesions on genomic DNA.The lesions can be recognized by the DDB1-DDB2and XPC-RAD23complexes.DDB1-DDB2forms an E3with CUL4and RBX1(not shown),which leads to DDB2autoubiquity-lation,resulting in its degradation,and XPC polyubiquitylation.XPC is stabilized through its interaction with RAD23,which contains a ubiq-uitin-like domain that interacts with the protea-some.This allows the subsequent steps of NER,such as the recruitment of XPA.(B)TC-NER repairs bulky lesions occurring on the transcribed DNA strand.RNA polymerase II acts as a lesion sensor.Two independent pathways can occur when RNA polymerase stalls after a lesion encounter.First (going right),TC-NER can be activated,with the CSB and CSA proteins playing a critical role in TC-NER.CSB associates with RNA polymerase and recruits CSA,which forms a CUL4-based E3with DDB1.The exact nature of the critical substrate of the E3associated with CSA is not known,but CSB is ubiquitylated and its degradation is delayed by USP7,which is brought to the stalled polymerase by UVSSA.Second (going down),the RNA polymerase can be ubiquitylated,extracted from chromatin,and degraded by the proteasome as a last resort.This pathway,in yeast,is initiated by Rad26-Def1(not shown),which leads to the Rsp5-dependent ubiquitylation of RNA polymerase.Rsp5can promote Lys63-ubiquitin chains but the DUB Ubp2trims these down.Monoubiquitylated RNA polymerase is then a substrate of an Elongin-Cullin 3complex.The Lys48-linked ubiquitin chains on RNA polymerase enable Cdc48to extract the stalled polymerase from chromatin,which then leads to its degradation.mine how TRIP12and UBR5affect RNF168levels and whether any physio-logical conditions affect this regulation.In this regard,TRIP12contains a WWE domain,which in other proteins binds to poly(ADP)ribose,suggesting that RNF168levels might be controlled by poly(ADP)ribosylation.Herpes simplex virus (HSV)infection also regulates the RNF8pathway,with the HSV ICP0protein—which is necessary for the transition between the viral latent and lytic phases—being an E3that targets RNF8and RNF168for degradation (Chaurushiya et al.,2012;Lilley et al.,2010).Specifically,ICP0targets RNF8for degradation through a ‘‘reverse-degron’’mechanism mediated by a phospho-depen-dent interaction between ICP0and the RNF8FHA domain (Chaurushiya et al.,2012).This RNF8and RNF168degradation not only obfuscates the DDR initiated by the linear HSV DNA but also relieves RNF8/168-dependent transcriptional repres-sion of the viral genome.While early work pointed to H2A-type histones being primary RNF8/168targets,mutational studies suggested that RNF8/RNF168target sites were distinct from the canonical H2AK119ubiquitylation sites (Huen et al.,2007).Indeed,RNF168was798Molecular Cell 49,March 7,2013ª2013Elsevier Inc.recently shown to target Lys13/15within the histone H2A N terminus (Gatti et al.,2012;Mattiroli et al.,2012).It will be impor-tant to determine whether and how H2A Lys13/15ubiquitylation may promote recruitment of proteins to chromatin flanking DSB sites and how this may functionally cooperate with other DSB-responsive histone modifications.In this regard,while H2A Lys13,and Lys15are located far from H2AK119on the nucleosome core particle,they are close to H2BK120,a residue ubiquitylated by the RNF20and RNF40E3ligases in collabora-tion with the RAD6E2(Zhu et al.,2005).RNF20and RNF40are also recruited to DSB sites via ATM-dependent mechanisms,to induce H2B monoubiquitylation (Moyal et al.,2011;Nakamura et al.,2011).These observations may help explain why Rnf8-deficient mouse embryo fibroblasts display reduced steady-state H2B K120ubiquitylation (Wu et al.,2009).Given the role of mammalian H2B ubiquitylation in regulating transcription and chromatin compaction (Weake and Workman,2008),thepotential crosstalk between H2A K13/K15and H2B K120ubiqui-tylation might at least in part explain RNF8/RNF168-dependent transcriptional silencing triggered near DSBs (Shanbhag et al.,2010).Histone ubiquitylation stimulated by DNA lesions is not limited to H2A K13/K15and H2B K120.Indeed,the E3BMI1-RING1B accumulates at DSB sites,where it is proposed to locally increase H2A/H2AX K119monoubiquitylation,which may partic-ipate in DNA-damage-induced transcriptional silencing (Gieni et al.,2011;Shanbhag et al.,2010).Furthermore,recent proteo-mic work found that all core histones along with histones H1,H2AZ,H2AX,and macro-H2A are ubiquitylated at multiple sites (Kim et al.,2011;Wagner et al.,2011).It will clearly be of interest to determine whether any of these modifications affect or are affected by responses to DNA lesions.Regulating DSB Responses by 53BP1and BRCA153BP1and BRCA1are the two main effectors of the RNF8pathway,yet they have diametrically opposed functions:53BP1opposes DNA end resection,an activity that promotes DSB repair by NHEJ (Noon and Goodarzi,2011),while BRCA1promotes HR and is somehow linked to initiation of end resection (Li and Greenberg,2012).BRCA1and 53BP1are thus essentially engaged in a tug of war that determines commitment to NHEJ or HR.This functional antagonism has profound implications for our understanding of BRCA1function as a tumor suppressor,since inactivation of 53BP1suppresses the lethality,tumorigen-esis,and sensitivity to most genotoxins associated with BRCA1loss of function (Bouwman et al.,2010;Bunting et al.,2010).A provocative implication of this work is that the function of BRCA1might act as a competitor or inhibitor of 53BP1,particu-larly in S/G2phases,when HR is upregulated (Chapman et al.,2012).The mechanism for 53BP1recruitment to DSB sites has been puzzling because it does not possess recognizable ubiqui-tin-binding regions.Instead,it contains a tandem Tudor domain that binds mono-or dimethylated histone H4Lys20(H4K20me1/2)and a tandem BRCT domain involved in protein-protein inter-actions (Botuyan et al.,2006).Notably,the Tudor but not the BRCT region of 53BP1is needed for its accumulation at DSB sites (Pryde et al.,2005).Recent work showed that the proteins L3MBTL1and JMJD2A bind to H4K20me1/2but are removed from chromatin upon DNA damage induction (Acs et al.,2011;Mallette et al.,2012).L3MBTL1removal requires the segregase VCP/p97,which is targeted to DSB sites through K48-linked ubiquitin and its cofactor NPL4(Acs et al.,2011),whereas the RNF8pathway promotes JMJD2A degradation (Mallette et al.,2012).A role of VCP/p97in 53BP1retention at DSB sites was also identified by Meerang et al.(2011),although the conclusions reached regarding mechanism differed.While a model for ubiquitylation simply acting to remove JMJD2A/L3MBTL1is attractive,it is difficult to reconcile it with the consti-tutive,Tudor-dependent association of 53BP1with chromatin (Bothmer et al.,2011)and with H2A K13/K15ubiquitylation being critical for 53BP1DSB recruitment (Mattiroli et al.,2012).The mechanism(s)for 53BP1recruitment at DSB sites will likely remain unresolved until the biochemical reconstitution of its RNF168-dependent chromatin binding isachieved.Figure 4.The Role of Ubiquitin in the Chromatin-Based Response to DNA Double-Strand Breaks(A)DSBs trigger the ATM-dependent phosphorylation of H2AX,which is read by MDC1.ATM can also phosphorylate MDC1to promote the recruitment of RNF8,an E3ligase.RNF8ubiquitylates an unknown factor on chromatin (X).This ubiquitylation is then read by the N-terminal ubiquitin binding domains of RNF168.RNF168ubiquitylates H2A,which provides a second recruitment signal for RNF168.In addition to RNF8/168,DSBs stimulate the recruitment of the BMI1-RING1B,which ubiquitylates H2A on the C terminus.Also shown are DUBs that antagonize this ubiquitylation event.(B)OTUB1antagonizes RNF168-dependent ubiquitylation by binding to E2s.RNF8and RNF168also stimulate the formation of Lys63-linked ubiquitin chains on chromatin.(C)The RNF168-dependent ubiquitylation of chromatin leads to the recruit-ment of multiple effectors that include 53BP1,which promotes NHEJ,and BRCA1,which promotes HR.Molecular Cell 49,March 7,2013ª2013Elsevier Inc.799BRCA1forms a dimeric RING-type E3with BARD1and,in addition to its role in HR,has also been linked to transcription-coupled DNA repair,DNA crosslink repair,and checkpoint control.While BRCA1recruitment at DSB sites clearly relies on RNF8-and RNF168-dependent formation of ubiquitin conju-gates (Lukas et al.,2011),exactly how BRCA1recognizes such ubiquitin conjugates is still under intense investigation.Long-term maintenance of BRCA1at DSB sites depends on its interaction with the RAP80complex—and the RAP80ubiquitin-binding UIM modules—but RAP80is dispensable for the initial accumulation of BRCA1at DSB sites (Hu et al.,2011;Yin et al.,2012b ).There is also vigorous debate about whether BRCA1E3ligase activity is crucial for DSB repair and tumor suppression,with the balance of opinion tilting toward it not being essential for DSB repair by HR (Li and Greenberg,2012;Shakya et al.,2011;Zhu et al.,2011).Indeed,a mutation in the RING domain (Brca1I26A )that only affects its interaction with E2conjugating enzymes results in cells that are proficient in repairing a targeted DSB by HR,along with mice that are pheno-typically normal with wild-type tumor latency (Li and Greenberg,2012;Shakya et al.,2011).However,a similar mutation in chicken DT40cells caused hypersensitivity to DNA damage caused by the topoisomerase I poison camptothecin (Sato et al.,2012).Additional work is clearly needed to define the specific function(s)for BRCA1E3ligase activity.Ubiquitin Control of the Fanconi Anemia PathwayFanconi anemia (FA)is a rare recessive genetic disorder charac-terized by developmental abnormalities,cancer predisposition,progressive bone-marrow failure,and defective repair of DNA interstrand crosslinks (ICLs)that prevent transcription and DNA replication (Garner and Smogorzewska,2011;Kim andD’Andrea,2012).There are currently 15known genes whose biallelic mutations yield FA (FANCA to FANCP),with their prod-ucts functioning in the three prime events of the FA pathway that occur in S phase:ICL recognition and excision,translesion synthesis,and HR-mediated repair (Knipscheer et al.,2009).The FA pathway is activated when replication forks encountering ICLs trigger chromatin association of the FA core complex (Figure 5).The FANCL subunit of this complex is a RING-type E3ligase that functions with the E2,UBE2T,to monoubiquitylate both subunits of the heterodimeric FANCD2-FANCI complex,which then provides a platform for coordinating repair processes (Joo et al.,2011).Specifically,in addition to ubiquitylation potentially helping anchor FANCD2-FANCI on chromatin,ubiqui-tylated FANCD2is recognized by the UBZ4UBD present in the structure-specific nuclease FAN1,although an interaction with the nuclease scaffold SLX4(FANCP)has also been proposed(Sengerova´et al.,2011).This promotes recruitment of these factors to sites of DNA damage,with the ensuing nucleolytic incisions triggering further stages of repair that include TLS and HR events discussed elsewhere in this review.Additional connections between the FA pathway and ubiquitin are high-lighted by work demonstrating that the FA core-complex-associ-ated factor,FAAP20,contains a UBD that binds RNF8-mediated ubiquitylations and cooperates with RNF8to promote recruit-ment of the FA core complex and FANCD2to ICLs (Yan et al.,2012).Deubiquitylases Acting in the DDRA well-characterized DUB is USP1,the prime FANCD2deubiqui-tylase,whose inactivation recapitulates many FA phenotypes,implying that both ubiquitylation and deubiquitylation must be appropriately controlled for the FA pathway to operate effectively (Kim and D’Andrea,2012).In this regard,the USP1-activating factor,UAF1/WDR48,possesses two tandem SUMO-like domains that mediate interactions with a SIM-related sequence in FANCI,thus targeting USP1to FANCD2/FANCI (Yang et al.,2011)(Figure 5).The DUBs USP3,USP16,BRCC36,POH1,and OTUB1are associated with negative regulation of the RNF8pathway,with USP3and USP16being first linked to this pathway through their ability to oppose H2A ubiquitylation (Weake and Workman,2008)and by USP3over-expression blocking RNF168accumulation at DSB sites (Doil et al.,2009).USP16,on the other hand,opposes RNF8/RNF168-mediated,DSB-induced transcriptional silencing (Shanbhag et al.,2010).BRCC36(BRCC3)—a JAMM/MPN(+)isopeptidase that displays strong selectivity for K63-linked ubiq-uitin chains and that is a component of the BRCA1-RAP80complex—accumulates at DSB sites downstream of RNF8/RNF168(Cooper et al.,2009;Dong et al.,2003;Shao et al.,2009;Sobhian et al.,2007;Wang and Elledge,2007).In addition,a second JAMM/MPN(+)protein with specificity against K63-linked ubiquitin chains,the proteasome-associated POH1/PSMD14DUB,has been linked to negative regulation of the RNF8pathway (Butler et al.,2012).Collectively,these findings suggest that proteasome-associated POH1and BRCA1/RAP80-associated BRCC36may collaborate to restrict K63-linked,RNF8/RNF168-dependent polyubiquitylation at DSB sites.Notably,the OTU family DUB,OTUB1,is anegativeFigure 5.The Role of Ubiquitin in the FA PathwayICLs are potent fork-blocking lesions.DNA replication fork stalling,along with FANCM and associated proteins (not shown),stimulates the recruitment of the multi-subunit FA core complex,which is an E3ligase.The catalytic subunit of this E3is FANCL and its E2is UBE2T.The FA core complex monoubiquitylates FANCD2-FANCI.FANCD2-FANCI ubiquitylation is read by FAN1and perhaps SLX4,which both contain a UBZ4-type ubiquitin binding domain.The USP1-UAF1DUB reverses FANCD2-FANCI ubiquitylation and is essential for the FA pathway.The recruitment of nucleases enables incision,unhooking of the lesion,TLS,and HR.800Molecular Cell 49,March 7,2013ª2013Elsevier Inc.。